Govt Issues Alert On Popular Pain Reliever, Cites Risks In Prolonged Use

Fridah Wangechi | 1 year ago
Pills in a vile FILE

The Pharmacy and Poisons Board has issued a public alert over the use of Diclofenac as a pain reliever, stating that prolonged use of the drug poses a grave risk to one's health that could potentially lead to death.

In a statement released on the regulatory board's social media page, regular use of Diclofenac has been proved detrimental to patients who rely on it for pain and inflammation relief for diseases such as arthritis.

Categorized in the Non-Steroidal Anti-Inflammatory drugs, the pain reliever has been linked to an increased risk of blood clots in the arteries, especially in patients with underlying heart and circulatory conditions or with certain cardiovascular risk factors.


The board has warned that the systemic use of the drug could expose one to the risk of heart attack or stroke especially if taken in high doses such as 150 milligrams.

Further, the drug is not recommended for patients with a history of heart attack, stroke or heart failure or blockages to blood vessels in the heart or brain, or who have had an operation to clear or bypass such blockages or circulatory problems that restrict blood flow to the limbs.

Smokers have also been cautioned as the practice exposes them to health problems such as high blood pressure, high blood cholesterol, or diabetes, and hence will require the doctor's assessment and advice on the best way to take Diclofenac.

"If you are on long-term diclofenac treatment, you will need to have your treatment reviewed to ensure that it is still right for you, or speak to your prescriber at your next scheduled treatment," the statement read in part.

"You should not stop taking your medication without talking to your health care professional and if you have any questions you are advised to speak with your heal care professional," it further warned.

Kenyans were advised against self-medication, as it should be only be dispensed or used upon prescription by a duly qualified health professional

They were also asked to ensure that they report to the board any adverse events or effects emanating from the use of the drug in a bid to ensure the safe use of the medicine.

Related Stories